Achieve Life Sciences, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €46.91K
    Gross profit
    -€46.91K
    SG&A expenses
    €18.26M
    R&D expenses
    €24.49M
    EBITDA
    -€31.27M
    D&A
    €145.00K
    EBIT
    -€21.11M
    Interest expenses
    €485.33K
    EBT
    -€43.00M
    Tax expenses
    €0.00
    Net income
    -€43.00M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.84M
    Changes in working capital
    €994.54K
    Operating cash flow
    -€33.88M
    Capex
    €0.00
    Other investing cash flow
    €11.65M
    Net investing cash flow
    €36.71M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €35.16M
    Debt repayment
    €0.00
    Other financing cash flow
    -€6.34M
    Net financing cash flow
    €28.82M
    Foreign exchange effects
    €0.00
    Net change in cash
    €31.66M
    Cash at end of period
    €44.26M
    Free cash flow
    -€33.88M

    Balance sheet

    Cash and cash equivalents
    €44.25M
    Cash and short-term investments
    €47.25M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €1.28M
    Total current assets
    €48.54M
    Property, plant & equipment
    €79.32K
    Goodwill
    €881.95K
    Intangible assets
    €736.10K
    Long-term investments
    €0.00
    Other non-current assets
    €35.82K
    Total non-current assets
    €1.73M
    Total assets
    €50.27M
    Accounts payable
    €1.04M
    Short-term debt
    €1.08M
    Other current liabilities
    €5.19M
    Total current liabilities
    €7.31M
    Long-term debt
    €7.42M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €7.42M
    Total liabilities
    €14.73M
    Common stock
    €100.65K
    Retained earnings
    -€197.14M
    Other equity
    €2.56K
    Total equity
    €35.54M
    Total liabilities and shareholders' equity
    €50.27M

    Company information

    Market capitalization
    €65.97M
    Employees
    25
    Enterprise Value
    €120.77M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -121.0% Much better than peer group: -8,260.7%
    ROA
    -85.5% Better than peer group: -94.2%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -51.3%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.72M

    Notifications